Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis

Human Molecular Genetics

Volumn 14, Issue 2, 2005, Pages 241-253

  Iwamoto, Kazuya ^a   Bundo, Miki ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZATROPINE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; DIPHENHYDRAMINE; DOXEPIN; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; GABAPENTIN; HALOPERIDOL; LITHIUM; MIRTAZAPINE; MITOCHONDRIAL DNA; OLANZAPINE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TIOTIXENE; TOPIRAMATE; TRAZODONE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM;

ADULT; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN MITOCHONDRION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC CODE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PH MEASUREMENT; PRIORITY JOURNAL; RESPIRATORY CHAIN; SCHIZOPHRENIA; UPREGULATION;

BIPOLAR DISORDER; BRAIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HYDROGEN-ION CONCENTRATION; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCHIZOPHRENIA;

EID: 12744278205     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi022     Document Type: Article

References (48)

1. Gershon, E. S. and Cloninger, C.R. (1994) Genetic Approaches to Mental Disorders. American Psychiatric Press, Washington, DC.
2. Berrettini, W.H. (2000) Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol. Psychiatry, 48, 531-538.
3. Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K. and Kato, T. (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders.1 Mol. Psychiatry, 9, 406-416.
4. Hakak, Y., Walker, J.R., Li, C., Wong, W.H., Davis, K.L., Buxbaum, J.D., Haroutunian, V. and Fienberg, A.A. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad Sci. USA, 98, 4746-4751.
5. Tkachev, D., Mimmack, M.L., Ryan, M.M., Wayland, M., Freeman, T., Jones, P.B., Starkey, M., Webster, M.J., Yolken, R.H. and Bahn, S. (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet, 362, 798-805.
6. Konradi, C., Eaton, M., MacDonald, M.L., Walsh, J., Benes, F.M. and Heckers, S. (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry, 61, 300-308.
7. Prabakaran, S., Swatton, J.E., Ryan, M.M., Huffaker, S.J., Huang, J.J., Griffin, J.L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K.S. et al. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry, 9, 684-697.
8. Kato, T. and Kato, N. (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord., 2, 180-190.
9. Kato, T., Takahashi, S., Shioiri, T. and Inubushi, T. (1993) Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J. Affect. Disord., 27, 53-59.
10. Kato, T., Stine, O.C., McMahon, F.J. and Crowe, R.R. (1997) Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol. Psychiatry, 42, 871-875.
11. Kato, T., Kunugi, H., Nanko, S. and Kato, N. (2001) Mitochondrial DNA polymorphisms in bipolar disorder. J. Affect. Disord., 62, 151-164.
12. Dager, S.R., Friedman, S.D., Parow, A., Demopulos, C., Stoll, A.L., Lyoo, I.K., Dunner, D.L. and Renshaw, P.F. (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry, 61, 450-458.
13. Ben-Shachar, D. (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J. Neurochem., 83 1241-1251.
14. Ben-Shachar, D. and Laifenfeld, D. (2004) Mitochondria, synaptic plasticity, and schizophrenia. Int. Rev. Neurobiol., 59 273-296.
15. Whatley, S.A., Curti, D. and Marchbanks, R.M. (1996) Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem. Res., 21, 995-1004.
16. Prince, J.A., Blennow, K., Gottfries, C.G., Karlsson, I and Oreland, L. (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21, 372-379.
17. Ben-Shachar, D., Zuk, R., Gazawi, H., Reshef, A., Sheinkman, A. and Klein, E. (1999) Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int. J. Neuropsychopharmacol., 2, 245-253.
18. Maurer, I., Zierz, S. and Moller, H. (2001) Evidence for a mitochon1drial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr. Res., 48, 125-136.
19. Dror, N., Klein, E., Karry, R., Sheinkman, A., Kirsh, Z., Mazor, M., Tzukerman, M. and Ben-Shachar, D. (2002) State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol. Psychiatry, 7, 995-1001.
20. Kung, L. and Roberts, R.C. (1999) Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse, 31, 67-75.
21. Bezchlibnyk, Y.B., Wang, J.F., McQueen, G.M. and Young, L.T. (2001) Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J. Neurochem., 79 826-834.
22. Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A. and Levitt, P. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67.
23. Vawter, M.P., Crook, J.M., Hyde, T.M., Kleinman, J.E., Weinberger, D.R., Becker, K.G. and Freed, W.J. (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res., 58, 11-20.
24. Chung, C., Tallerico, T. and Seeman, P. (2003) Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse, 50, 29-34.
25. Middleton, F.A., Mirnics, K., Pierri, J.N., Lewis, D.A. and Levitt, P. (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci., 22 2718-2729.
26. Barton, A.J., Pearson, R.C., Najlerahim, A. and Harrison, P.J. (1993) Pre- and postmortem influences on brain RNA. J. Neurochem. 61, 1-11.
27. Kingsbury, A.E., Foster, O.J., Nisbet, A.P., Cairns, N., Bray, L., Eve, D.J., Lees, A.J. and Marsden, C.D. (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res. Mol. Brain Res., 28, 311-318.
28. Bahn, S., Augood, S.J., Ryan, M., Standaert, D.G., Starkey, M. and Emson, P.C. (2001) Gene expression profiling in the post-mortem human brain - no cause for dismay. J. Chem. Neuroanat., 22, 79-94.
29. Li, J.Z., Vawter, M.P., Walsh, D.M., Tomita, H., Evans, S.J., Choudary, P.V., Lopez, J.F., Avelar, A., Shokoohi, V., Chung, T. et al. (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet., 13, 609-616.
30. Tomita, H., Vawter, M.P., Walsh, D.M., Evans, S.J., Choudary, P.V., Li, J., Overman, K.M., Atz, M.E., Myers, R.M., Jones, E.G. et al. (2004) Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol. Psychiatry, 55, 346-352.
31. Haas, R., Stumpf, D.A., Parks, J.K. and Eguren, L. (1981) Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology, 31, 1473-1476.
32. Rumbach, L., Warter, J.M., Rendon, A., Marescaux, C., Micheletti, G. and Waksman, A. (1983) Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. J. Neurol. Sci., 61, 417-423.
33. Keller, B.J., Yamanaka, H. and Thurman, R.G. (1992) Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents. Toxicology, 71, 49-61.
34. Weinbach, E.C., Costa, J.L., Nelson, B.D., Claggett, C.E., Hundal, T., Bradley, D. and Morris, S.J. (1986) Effects of tricyclic antidepressant drugs on energy-linked reactions in mitochondria. Biochem. Pharmacol., 35, 1445-1451.
35. Curti, C., Mingatto, F.E., Polizello, A.C., Galastri, L.O., Uyemura, S.A. and Santos, A.C. (1999) Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity. Mol. Cell. Biochem., 199, 103-109.
36. Burkhardt, C., Kelly, J.P., Lim, Y.H., Filley, C.M. and Parker, W.D., Jr (1993) Neuroleptic medications inhibit complex I of the electron transport chain. Ann. Neurol., 33, 512-517.
37. Maurer, I. and Moller, H.J. (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol. Cell. Biochem., 174, 255-259.
38. Barrientos, A., Marin, C., Miro, O., Casademont, J., Gomez, M., Nunes, V., Tolosa, E., Urbano-Marquez, A. and Cardellach, F. (1998) Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats. J. Neurosci. Res., 53 475-481.
39. Whatley, S.A., Curti, D., Das Gupta, F., Ferrier, I.N., Jones, S., Taylor, C. and Marchbanks, R.M. (1998) Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol. Psychiatry 3, 227-237.
40. Balijepalli, S., Kenchappa, R.S., Boyd, M.R. and Ravindranath, V. (2001) Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics. Neurochem. Int., 38, 425-435.
41. Modica-Napolitano, J.S., Lagace, C.J., Brennan, W.A. and Aprille, J.R. (2003) Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Arch. Pharm. Res., 26, 951-959.
42. Washizuka, S., Kakiuchi, C., Mori, K., Kunugi, H., Tajima, O., Akiyama, T., Nanko, S. and Kato, T. (2003) Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am. J. Med. Genet., 120B, 72-78.
43. Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U. and Speed, T.P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
44. Liu, G., Loraine, A.E., Shigeta, R., Cline, M., Cheng, J., Valmeekam, V., Sun, S., Kulp, D. and Siani-Rose, M.A. (2003) NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res., 31, 82-86.
45. Storey, J.D. and Tibshirani, R. (2003) Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA, 100, 9440-9445.
46. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
47. Efron, B. and Tibshirani, R.J. (1993) An Introduction to the Bootstrap. Chapman and Hall, London.
48. Iwamoto, K., Bundo, M., Yamamoto, M., Ozawa, H., Saito, T. and Kato, T. (2004) Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci. Res., 49, 379-385.